- Home
- EDIT vs WOLF Comparison
EDIT vs WOLF Comparison
Compare EDIT & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- WOLF
- Stock Information
- Founded
- EDIT 2013
- WOLF 1987
- Country
- EDIT United States
- WOLF United States
- Employees
- EDIT N/A
- WOLF N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- WOLF Semiconductors
- Sector
- EDIT Health Care
- WOLF Technology
- Exchange
- EDIT Nasdaq
- WOLF Nasdaq
- Market Cap
- EDIT 179.1M
- WOLF 200.8M
- IPO Year
- EDIT 2016
- WOLF 1993
- Fundamental
- Price
- EDIT $2.75
- WOLF $1.50
- Analyst Decision
- EDIT Buy
- WOLF Hold
- Analyst Count
- EDIT 12
- WOLF 14
- Target Price
- EDIT $6.20
- WOLF $10.67
- AVG Volume (30 Days)
- EDIT 3.3M
- WOLF 188.3M
- Earning Date
- EDIT 08-06-2025
- WOLF 08-20-2025
- Dividend Yield
- EDIT N/A
- WOLF N/A
- EPS Growth
- EDIT N/A
- WOLF N/A
- EPS
- EDIT N/A
- WOLF N/A
- Revenue
- EDIT $35,837,000.00
- WOLF $761,300,000.00
- Revenue This Year
- EDIT N/A
- WOLF N/A
- Revenue Next Year
- EDIT N/A
- WOLF $11.97
- P/E Ratio
- EDIT N/A
- WOLF N/A
- Revenue Growth
- EDIT N/A
- WOLF N/A
- 52 Week Low
- EDIT $0.91
- WOLF $0.39
- 52 Week High
- EDIT $6.05
- WOLF $3.33
- Technical
- Relative Strength Index (RSI)
- EDIT 61.68
- WOLF 53.98
- Support Level
- EDIT $2.48
- WOLF $1.25
- Resistance Level
- EDIT $3.24
- WOLF $3.33
- Average True Range (ATR)
- EDIT 0.26
- WOLF 0.43
- MACD
- EDIT 0.02
- WOLF 0.13
- Stochastic Oscillator
- EDIT 57.94
- WOLF 45.92
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About WOLF Wolfspeed Inc.
Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.